Thrivent Financial For Lutherans Xencor Inc Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Xencor Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 116,369 shares of XNCR stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
116,369
Previous 51,189 127.33%
Holding current value
$2.91 Million
Previous $969,000 141.49%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$15.7 - $21.65 $1.02 Million - $1.41 Million
65,180 Added 127.33%
116,369 $2.34 Million
Q2 2024

Aug 13, 2024
SELL
$18.21 - $24.5 $29,518 - $39,714
-1,621 Reduced 3.07%
51,189 $969,000
Q1 2024

May 14, 2024
SELL
$18.65 - $26.52 $26,744 - $38,029
-1,434 Reduced 2.64%
52,810 $1.17 Million
Q4 2023

Feb 14, 2024
SELL
$16.53 - $21.42 $19,918 - $25,811
-1,205 Reduced 2.17%
54,244 $1.15 Million
Q3 2023

Nov 14, 2023
SELL
$20.08 - $25.39 $46,645 - $58,980
-2,323 Reduced 4.02%
55,449 $1.12 Million
Q2 2023

Aug 14, 2023
SELL
$24.77 - $29.9 $39,954 - $48,228
-1,613 Reduced 2.72%
57,772 $1.44 Million
Q1 2023

May 17, 2023
SELL
$25.95 - $36.95 $54,027 - $76,929
-2,082 Reduced 3.39%
59,385 $1.66 Million
Q4 2022

Feb 08, 2023
SELL
$24.79 - $30.86 $6,048 - $7,529
-244 Reduced 0.4%
61,467 $1.6 Million
Q3 2022

Nov 14, 2022
BUY
$24.62 - $32.44 $79,104 - $104,229
3,213 Added 5.49%
61,711 $1.6 Million
Q2 2022

Aug 16, 2022
BUY
$19.74 - $29.01 $214,948 - $315,889
10,889 Added 22.87%
58,498 $1.6 Million
Q1 2022

May 13, 2022
BUY
$26.68 - $41.63 $426 - $666
16 Added 0.03%
47,609 $1.27 Million
Q4 2021

Feb 16, 2022
BUY
$33.67 - $43.44 $15,117 - $19,504
449 Added 0.95%
47,593 $1.91 Million
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $13,945 - $16,234
-455 Reduced 0.96%
47,144 $1.54 Million
Q2 2021

Aug 19, 2021
SELL
$34.33 - $44.68 $34 - $44
-1 Reduced -0.0%
47,599 $1.64 Million
Q1 2021

May 17, 2021
BUY
$40.81 - $53.88 $1,754 - $2,316
43 Added 0.09%
47,600 $2.05 Million
Q4 2020

Feb 16, 2021
BUY
$36.63 - $47.63 $3,369 - $4,381
92 Added 0.19%
47,557 $2.08 Million
Q3 2020

Nov 10, 2020
BUY
$30.09 - $43.02 $179,155 - $256,141
5,954 Added 14.34%
47,465 $1.84 Million
Q2 2020

Aug 12, 2020
BUY
$27.76 - $33.42 $4,275 - $5,146
154 Added 0.37%
41,511 $1.35 Million
Q1 2020

May 15, 2020
BUY
$20.69 - $37.79 $42,704 - $77,998
2,064 Added 5.25%
41,357 $1.24 Million
Q4 2019

Feb 13, 2020
BUY
$32.75 - $41.43 $5,043 - $6,380
154 Added 0.39%
39,293 $1.35 Million
Q3 2019

Nov 14, 2019
BUY
$33.73 - $46.27 $1.32 Million - $1.81 Million
39,139 New
39,139 $1.32 Million

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.49B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email